- Home
- TVTX vs CENTA Comparison
TVTX vs CENTA Comparison
Compare TVTX & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- CENTA
- Stock Information
- Founded
- TVTX 2008
- CENTA 1955
- Country
- TVTX United States
- CENTA United States
- Employees
- TVTX N/A
- CENTA N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- CENTA Consumer Specialties
- Sector
- TVTX Health Care
- CENTA Consumer Discretionary
- Exchange
- TVTX Nasdaq
- CENTA Nasdaq
- Market Cap
- TVTX 1.8B
- CENTA 2.0B
- IPO Year
- TVTX N/A
- CENTA 1993
- Fundamental
- Price
- TVTX $21.98
- CENTA $32.05
- Analyst Decision
- TVTX Strong Buy
- CENTA Strong Buy
- Analyst Count
- TVTX 12
- CENTA 5
- Target Price
- TVTX $30.08
- CENTA $41.50
- AVG Volume (30 Days)
- TVTX 1.8M
- CENTA 245.6K
- Earning Date
- TVTX 02-20-2025
- CENTA 02-05-2025
- Dividend Yield
- TVTX N/A
- CENTA N/A
- EPS Growth
- TVTX N/A
- CENTA N/A
- EPS
- TVTX N/A
- CENTA 1.82
- Revenue
- TVTX $233,175,000.00
- CENTA $3,222,363,000.00
- Revenue This Year
- TVTX $62.88
- CENTA $2.92
- Revenue Next Year
- TVTX $57.60
- CENTA $2.16
- P/E Ratio
- TVTX N/A
- CENTA $17.61
- Revenue Growth
- TVTX 60.55
- CENTA N/A
- 52 Week Low
- TVTX $5.12
- CENTA $27.70
- 52 Week High
- TVTX $25.29
- CENTA $41.03
- Technical
- Relative Strength Index (RSI)
- TVTX 53.52
- CENTA 48.08
- Support Level
- TVTX $22.48
- CENTA $32.17
- Resistance Level
- TVTX $23.69
- CENTA $34.14
- Average True Range (ATR)
- TVTX 1.22
- CENTA 0.97
- MACD
- TVTX -0.02
- CENTA -0.02
- Stochastic Oscillator
- TVTX 41.10
- CENTA 33.19
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.
About CENTA Central Garden & Pet Company Nonvoting
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.